Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

GetNews Releases

Thu, Dec 12th, 2024
Contributor Content

This article could contain syndicated content. We have not reviewed, approved, or endorsed the content and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here

PD-LID Market Growth to Accelerate in Forecast Period (2024-2034), DelveInsight Analyzes | Adamas Pharma, Novartis, EMD Serono, PharmaTher, Neurolixis, Bukwang Pharma, Vistagen Therapeutics, Avanir

The Key PD-LID Companies in the market include - PharmaTher, Neurolixis, Bukwang Pharmaceutical, Vistagen Therapeutics, Adamas Pharmaceuticals, Inc., Novartis, EMD Serono, Avanir Pharmaceuticals, UCB Pharma,...

Early Bird Registration Now Open for Summer 2025 North American Jewish Choral Festival

"“The Festival is for anyone who wants to celebrate the joy of Jewish music,” says Maestro Matthew Lazar, Festival Founder and Director. “The participants include amateur singers, professionals,...

Pioneers Redefining Business Civilization, Creators of Value: IVMCR Completes Brand Upgrade

Today, Jingxiong Zhanzu, the founder of IVMCR, announced the successful completion of a brand upgrade for IVMCR's core philosophy and its multimedia collaboration platform (Instant Voice, Multimedia, Collaboration...

Diabetic Retinopathy Treatment Market 2034: Clinical Trials, EMA, PDMA, FDA Approvals, Medication, Patient Pool, and Companies DelveInsight

"Diabetic Retinopathy Treatment Market"Diabetic Retinopathy companies are Genentech, Inc., Regeneron Pharmaceuticals, Roche, Opthea Limited, Regenxbio, Kodiak Sciences, OcuTerra Therapeutics, Ocuphire...

Autosomal Dominant Polycystic Kidney Disease Treatment Market 2034: Clinical Trials, EMA, PDMA, FDA Approvals, Medication, Patient Pool, and Companies DelveInsight

"Autosomal Dominant Polycystic Kidney Disease Treatment Market"Autosomal Dominant Polycystic Kidney Disease Companies are Otsuka America Pharmaceuticals, Vertex Pharmaceuticals, Pfizer, Otsuka Pharma,...

Scottsdale Entrepreneur Luke Johnson Announces Scholarship to Support Aspiring Business Innovators Nationwide

Luke Johnson Scottsdale ArizonaScottsdale, Arizona - The Luke Johnson Scholarship for Entrepreneurs is now accepting applications from ambitious undergraduate students across the United States who are...

Joseph Rallo Scholarship for Entrepreneurs to Award $10,000 to the Next Generation of Innovators

Joseph RalloNew York, New York - The Joseph Rallo Scholarship for Entrepreneurs, a one-time award of $10,000, has been established to support the next generation of innovators and business leaders. This...

Mark Belter Grant for Aspiring Entrepreneurs: Pioneering Opportunities for Undergraduate Visionaries in Business Innovation

Mark BelterNorth Ridgeville, OH - The Mark Belter Grant for Aspiring Entrepreneurs is now accepting applications from undergraduate students across the United States who are eager to transform their entrepreneurial...

Nihar Gala Announces Grant to Support Aspiring Healthcare Professionals Across the Nation

Nihar GalaMillsboro, DE - The Nihar Gala Grant for Healthcare Students is now open for applications, offering a $1,000 award to one exceptional undergraduate student pursuing a career in healthcare. Spearheaded...

Dr. Zachary Solomon Announces Prestigious Scholarship to Foster Innovation in Medicine

Dr. Zachary SolomonPhiladelphia, PA - The Dr. Zachary Solomon Scholarship for Medical Students, established by cardiothoracic surgeon Dr. Zachary Solomon, offers a unique opportunity for undergraduate...

Tweets @Barchart

Barchart
@Barchart
Hedge Fund turns Bearish on Brazilian Stocks for the first time since 2016 🚨 https://t.co/YVVdxNpUu6
Barchart
@Barchart
U.S. Treasury Volatility $MOVE plunges to lowest level since January 2022 🚨 https://t.co/azPuQykjkm
Barchart
@Barchart
BREAKING 🚨: United States People in the U.S. now live an average of 12.4 years with an illness, the most of any country in the world https://t.co/Uv5MHIHjna https://t.co/AwcJZwjZus
Barchart
@Barchart
U.S. Equity ETFs saw an inflow of $149 Billion in November, the largest monthly inflow in history 🚨 https://t.co/s51tyeBRP0
Barchart
@Barchart
There is now a 98.5% chance of a 25 bps interest rate cut at next week's FOMC meeting 🚨 https://t.co/9CymnXy8Lk
Barchart
@Barchart
2 Large Pizzas or $1 Billion - What would you rather have? In 2010, Laszlo Hanyecz spent 10,000 $BTC on 2 Large Pizzas. Today, that would be worth more than $1 Billion! Laszlo, we thank you for your sacrifice 🫡🤝🍕 https://t.co/1ieXUIUY1U
Barchart
@Barchart
Nasdaq hits 20,000 for the first time in history 🚨 Congrats everyone, we did it 🫡🥳🍾 https://t.co/4Xc2HMJOvj
Barchart
@Barchart
Fewer than 32% of S&P 500 companies have outperformed the $SPX this year, one of the lowest readings over the last 50 years. In fact, the performance from 2023-24 is almost identical to that of 1998-1999 🚨 Probably Fine https://t.co/djPilHPIBY https://t.co/DyvAQEW1C4
Barchart
@Barchart

Chart of the Day

Netflix Inc (NFLX)

Summary Netflix (NFLX) shows strong technical indicators with 100% buy signals, a 103.86% gain in the last year, and a Trend Seeker buy signal. Fundamental factors include a market cap of $390 billion, a P/E ratio of 51.71, and expected revenue growth of 15.30% this year. Analysts are mixed with...
Read More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar